Marc‐André Langlois

3.6k total citations · 1 hit paper
76 papers, 2.2k citations indexed

About

Marc‐André Langlois is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Marc‐André Langlois has authored 76 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 18 papers in Molecular Biology and 17 papers in Epidemiology. Recurrent topics in Marc‐André Langlois's work include SARS-CoV-2 and COVID-19 Research (35 papers), COVID-19 Clinical Research Studies (21 papers) and HIV Research and Treatment (15 papers). Marc‐André Langlois is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (35 papers), COVID-19 Clinical Research Studies (21 papers) and HIV Research and Treatment (15 papers). Marc‐André Langlois collaborates with scholars based in Canada, United States and United Kingdom. Marc‐André Langlois's co-authors include Michael S. Neuberger, Yannick Galipeau, Silvestro G. Conticello, Tyler M. Renner, Kasandra Bélanger, Matthew Greig, Chaojie Liu, Jack Puymirat, John J. Rossi and Vera A. Tang and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Marc‐André Langlois

68 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Platelets Can Associate With SARS-CoV-2 RNA and Are Hyperactivated in COVID-19

2020 355 citations Younes Zaid, Florian Puhm et al. Circulation Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc‐André Langlois Canada	22	1.1k	838	447	394	382	76	2.2k
Massimo Gentile Italy	21	359 0.3×	1.2k 1.4×	261 0.6×	779 2.0×	425 1.1×	52	2.4k
Matthias Tenbusch Germany	28	422 0.4×	491 0.6×	216 0.5×	886 2.2×	452 1.2×	91	2.1k
Richard McFarland United States	17	425 0.4×	329 0.4×	719 1.6×	1.4k 3.6×	416 1.1×	30	2.4k
Julio C. C. Lorenzi United States	20	1.0k 0.9×	380 0.5×	759 1.7×	554 1.4×	242 0.6×	36	1.8k
Hélène Péré France	20	414 0.4×	335 0.4×	74 0.2×	473 1.2×	493 1.3×	84	1.8k
Sabine M. Lang United States	18	381 0.4×	1.1k 1.3×	338 0.8×	1.2k 3.1×	592 1.5×	25	2.5k
Katharina Grabmeier‐Pfistershammer Austria	29	399 0.4×	333 0.4×	210 0.5×	1.3k 3.4×	715 1.9×	86	2.6k
Xianfang Wu United States	20	390 0.4×	972 1.2×	78 0.2×	672 1.7×	551 1.4×	37	2.2k
Thomas M. McHugh United States	22	489 0.5×	240 0.3×	816 1.8×	806 2.0×	482 1.3×	36	2.1k
Ana E. Sousa Portugal	28	471 0.4×	351 0.4×	1.1k 2.5×	2.0k 5.0×	437 1.1×	87	2.8k

Countries citing papers authored by Marc‐André Langlois

Since Specialization

Citations

This map shows the geographic impact of Marc‐André Langlois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc‐André Langlois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc‐André Langlois more than expected).

Fields of papers citing papers by Marc‐André Langlois

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc‐André Langlois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc‐André Langlois. The network helps show where Marc‐André Langlois may publish in the future.

Co-authorship network of co-authors of Marc‐André Langlois

This figure shows the co-authorship network connecting the top 25 collaborators of Marc‐André Langlois. A scholar is included among the top collaborators of Marc‐André Langlois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc‐André Langlois. Marc‐André Langlois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thériault, Mathieu, Marc‐André Langlois, Jean‐François Masson, et al.. (2025). Impact of SARS-CoV-2 vaccination and of seasonal variations on the innate immune inflammatory response. Frontiers in Immunology. 15. 1513717–1513717.

Figueroa, Juan David, Ryan Tu, Marcelo Muñoz, et al.. (2025). Ultrashort Peptides as Stabilizing Agents for Colloidal Nanogold. ACS Applied Materials & Interfaces. 17(14). 21601–21613. 1 indexed citations

Galipeau, Yannick, Corey Arnold, Martin Pelchat, et al.. (2025). Autoantibodies targeting angiotensin‐converting enzyme 2 are prevalent and not induced by SARS ‐ CoV ‐2 infection. The FASEB Journal. 39(4). e70390–e70390.

Galipeau, Yannick, Curtis Cooper, & Marc‐André Langlois. (2025). Autoantibodies in COVID-19: implications for disease severity and clinical outcomes. Frontiers in Immunology. 15. 1509289–1509289. 4 indexed citations

Siragam, Vinayakumar, et al.. (2024). Seasonal human coronaviruses OC43, 229E, and NL63 induce cell surface modulation of entry receptors and display host cell-specific viral replication kinetics. Microbiology Spectrum. 12(7). e0422023–e0422023. 3 indexed citations

Gravel, Christopher A., et al.. (2024). Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity. npj Vaccines. 9(1). 226–226. 4 indexed citations

Galipeau, Yannick, et al.. (2024). Reduced seasonal coronavirus incidence in high‐risk population groups during the COVID‐19 pandemic. Immunity Inflammation and Disease. 12(7). e1342–e1342. 2 indexed citations

Almeida, N., Ian Schiller, Danbing Ke, et al.. (2024). The effect of dose-interval on antibody response to mRNA COVID-19 vaccines: a prospective cohort study. Frontiers in Immunology. 15. 1330549–1330549. 3 indexed citations

Colmegna, Inés, Nathalie Amiable, Emmanouil Rampakakis, et al.. (2023). COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary series. RMD Open. 9(4). e003400–e003400. 7 indexed citations

10.

Renner, Tyler M., Kasandra Bélanger, Matthew Greig, et al.. (2023). Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles. Nature Communications. 14(1). 16–16. 7 indexed citations

11.

Galipeau, Yannick, Danijela Konforte, Mohamed Abou El Hassan, et al.. (2023). Cross-sectional Characterization of SARS-CoV-2 Antibody Levels and Decay Rates Following Infection of Unvaccinated Elderly Individuals. Open Forum Infectious Diseases. 10(8). ofad384–ofad384. 2 indexed citations

12.

Bouassa, Ralph‐Sydney Mboumba, Suzanne Samarani, Zabrina L. Brumme, et al.. (2023). SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study). Viruses. 15(2). 575–575. 7 indexed citations

13.

Galipeau, Yannick, et al.. (2023). Continuous false positive results by SARS-CoV-2 rapid antigen testing: a case report. Frontiers in Public Health. 11. 1240308–1240308. 2 indexed citations

14.

Galipeau, Yannick, Corey Arnold, Raphael Saginur, et al.. (2023). Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccination. BMJ Open. 13(10). e077714–e077714. 5 indexed citations

15.

Galipeau, Yannick, et al.. (2022). Seasonal respiratory virus circulation was diminished during the COVID‐19 pandemic. Influenza and Other Respiratory Viruses. 17(1). e13065–e13065. 17 indexed citations

16.

Puhm, Florian, Isabelle Allaeys, Isabelle Dubuc, et al.. (2022). Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells. Blood Advances. 6(12). 3593–3605. 40 indexed citations

17.

O’Dwyer, Conor, Renske D.M. Steenbergen, Tyler M. Renner, et al.. (2020). In Vitro Hepatitis C Virus Infection and Hepatic Choline Metabolism. Viruses. 12(1). 108–108. 8 indexed citations

18.

Zaid, Younes, Florian Puhm, Isabelle Allaeys, et al.. (2020). Platelets Can Associate With SARS-CoV-2 RNA and Are Hyperactivated in COVID-19. Circulation Research. 127(11). 1404–1418. 355 indexed citations breakdown →

19.

Bélanger, Kasandra, et al.. (2013). Deamination intensity profiling of human APOBEC3 protein activity along the near full-length genomes of HIV-1 and MoMLV by HyperHRM analysis. Virology. 448. 168–175. 7 indexed citations

20.

Langlois, Marc‐André, Youssef El Fakhry, & Walid Mourad. (2003). Zinc-binding Sites in the N Terminus of Mycoplasma arthritidis-derived Mitogen Permit the Dimer Formation Required for High Affinity Binding to HLA-DR and for T Cell Activation. Journal of Biological Chemistry. 278(25). 22309–22315. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact